Status:
UNKNOWN
Virtual Reality Avatar Therapy for People Hearing Voices
Lead Sponsor:
Psychiatric University Hospital, Zurich
Conditions:
Psychosis
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Hearing voices is probably the worst form of acoustic hallucinations; which can be experienced as severely disturbing and is influenced by diverse factors including the ability of the individual to in...
Eligibility Criteria
Inclusion
- Consistent acoustic hallucinations, with the presence of voices for at least two months.
- Participants are competent to give informed consent, as determined by the referring physician or psychiatrist.
- German language proficiency as a native speaker or level B1 Common European Framework of Reference for Languages (CEFRL)
Exclusion
- Current neurological disorder.
- Current substance use or withdrawal.
- Concomitant group psychotherapeutic intervention.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04099940
Start Date
July 1 2021
End Date
December 31 2025
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychiatrische Universitätsklinik Zürich
Zurich, Switzerland, 8032